Survival and prognostic factors of death risk in antiphospholipid syndrome: results of 8-year follow-up

Survival and prognostic factors of death risk in antiphospholipid syndrome: results of 8-year follow-up

Aim. To evaluate survival and mortality in antiphospholipid syndrome (APS) as well as prognostic factors of APS deterioration. Material and methods. We retrospectively studied 248 case histories of patients admitted to the Institute of Rheumatology for 8 years. Primary APS was diagnosed in 35 patien...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	T M Reshetnyak, Z S Alekberova, G P Kotelnikova, E N Alexandrova, E S Mack, S G Radenska-Lopovok, L A Kalashnikova, V A Nasonova
Fformat:	Erthygl
Iaith:	Russian
Cyhoeddwyd:	"Consilium Medicum" Publishing house 2003-05-01
Cyfres:	Терапевтический архив
Pynciau:	antiphospholipid syndrome primary and secondary survival prognostic factors systemic lupus erythematosus
Mynediad Ar-lein:	https://ter-arkhiv.ru/0040-3660/article/view/29375

Eitemau Tebyg

Anticardiolipine antibodies in skin and muscle eluates of patients with primary and secondary antiphospholipid syndrome
gan: Z S Alekberova, et al.
Cyhoeddwyd: (2004-08-01)

Clinical and endoscopic assessment of gastric state in systemic lupus erythematosus and antiphospholipid syndrome
gan: I. A. Doroshkevich, et al.
Cyhoeddwyd: (2004-06-01)

ANTIPHOSPHOLIPID SYNDROME: DIAGNOSIS AND CLINICAL MANIFESTATIONS (A LECTURE)
gan: Tat’yana M Reshetnyak
Cyhoeddwyd: (2014-03-01)

Blood nitrates content in patients with systemic lupus erythematosus and antiphospholipid syndrome
gan: D V Reshetnyak, et al.
Cyhoeddwyd: (2004-05-01)

ANTIPHOSPHOLIPID SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS: WHAT DISEASE IS A CAUSE OF ORGAN DAMAGES?
gan: F. A. Cheldieva, et al.
Cyhoeddwyd: (2020-04-01)

Antiphospholipid syndrome and exogenic factors ofthromboses risk
gan: E S Mach, et al.
Cyhoeddwyd: (2004-11-01)

Von Willebrand factor antigen in systemic lupus erythematosus and antiphospholipid syndrome
gan: A A Novikov, et al.
Cyhoeddwyd: (2004-08-01)

C-reactive protein in antiphospholipid syndrome: relationship with cardiovascular pathology
gan: N V Seredavkina, et al.
Cyhoeddwyd: (2009-08-01)

Pediatric antiphospholipid syndrome
gan: Petrović Gordana, et al.
Cyhoeddwyd: (2023-01-01)

Antibodies to the phosphatidylserine/prothrombin complex in the diagnosis of antiphospholipid syndrome
gan: Tatiana M. Reshetnyak, et al.
Cyhoeddwyd: (2022-06-01)

Clinical and immunological features of primary and secondary antiphospholipid syndrome
gan: T M Reshetnvak, et al.
Cyhoeddwyd: (2004-08-01)

Echocardiographic Abnormalities and Antiphospholipid Antibodies in Patients with Systemic Lupus Erythematosus
gan: Creso Abreu Falcão, et al.
Cyhoeddwyd: (2002-09-01)

The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus
gan: M. Taraborelli, et al.
Cyhoeddwyd: (2016-12-01)

Primary antiphospholipid syndrome progressing to systemic lupus erythematosus: a case report
gan: Rocco Manganelli, et al.
Cyhoeddwyd: (2013-04-01)

SECONDARY ANTIPHOSPHOLIPID SYNDROME REVEALED BY THE SUDDEN ONSET OF PNEUMONIA-CASE REPORT
gan: Lazovic Biljana, et al.
Cyhoeddwyd: (2019-12-01)

Hyperhomocysteinemia - an additional risk factor of thrombosis in systemic lupus erythematosus and antiphospholipid syndrome
gan: I. E. Shirokova, et al.
Cyhoeddwyd: (2003-08-01)

STUDIES DEVOTED TO ANTIPHOSPHOLIPID SYNDROME AT THE V.A. NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY: MAIN ACHIEVEMENTS (ON THE OCCASION OF THE 40th ANNIVERSARY OF THE DISSERTATION BOARD)
gan: T. M. Reshetnyak
Cyhoeddwyd: (2017-01-01)

Global antiphospholipid syndrome score (GAPSS) in patients with systemic lupus erythematosus
gan: F. A. Cheldieva, et al.
Cyhoeddwyd: (2022-11-01)

An Antiphospholipid Antibody Profile as a Biomarker for Thrombophilia in Systemic Lupus Erythematosus
gan: Ryo Hisada, et al.
Cyhoeddwyd: (2023-03-01)

Type I interferon pathway activation across the antiphospholipid syndrome spectrum: associations with disease subsets and systemic antiphospholipid syndrome presentation
gan: Irene Cecchi, et al.
Cyhoeddwyd: (2024-03-01)

Vaccination of pneumococcal infection in patients with systemic lupus erythe matosus and antiphospholipid syndrome: experience of 6 years of use
gan: G. M. Tarasova, et al.
Cyhoeddwyd: (2023-06-01)

Thrombotic microangiopathy in rheumatology: a link between thrombosis and autoimmunity
gan: Evgeny L. Nasonov, et al.
Cyhoeddwyd: (2020-06-01)

Digital ulcers as presenting symptom of secondary antiphospholipid syndrome
gan: Karen Cravero, PhD, et al.
Cyhoeddwyd: (2022-11-01)

Origin and pathogenesis of antiphospholipid antibodies
gan: C.M. Celli, et al.
Cyhoeddwyd: (1998-06-01)

Netosis in the pathogenesis of antiphospholipid syndrome and systemic lupus erythematosus
gan: K. S. Nurbaeva, et al.
Cyhoeddwyd: (2021-10-01)

RECURRENT FETAL LOSS IN THE PRIMARY ANTIPHOSPHOLIPID SYNDROME (CASE REPORT)
gan: Z S Alekberova, et al.
Cyhoeddwyd: (2000-02-01)

Secondary antiphospholipid syndrome in systemic lupus erythematosus – screening, diagnosis and treatment methods
gan: Andrei-Bogdan Mihailescu, et al.
Cyhoeddwyd: (2022-06-01)

Extensive abdominal wall ulceration as a late manifestation of antiphospholipid syndrome: a case report
gan: Yogesh Sharma, et al.
Cyhoeddwyd: (2018-08-01)

Anesthetic management of patient with systemic lupus erythematosus and antiphospholipid antibodies syndrome for laparoscopic nephrectomy and cholecystectomy
gan: Rashid Saeed Khokhar, et al.
Cyhoeddwyd: (2015-01-01)

Acute Systemic Lupus Erythematous and Antiphospholipid Syndrome With Cardiac Complications
gan: Manish Motwani, MBChB, PhD, et al.
Cyhoeddwyd: (2019-08-01)

Contraception for antiphospholipid syndrome and systemic lupus erythematosus (according to the recommendations of the European Alliance of Associations for Rheumatology/American College of Rheumatology, EULAR/ACR)
gan: T. M. Reshetnyak, et al.
Cyhoeddwyd: (2024-03-01)

Difficulties in management of patients with systemic lupus erythematosus and antiphospholipid syndrome in combination with melanoma and infiltrative tuberculosis (clinical observations)
gan: A. A. Shumilova, et al.
Cyhoeddwyd: (2021-08-01)

Splenic infarcts in a lady with systemic lupus erythematosus and negative antiphospholipid antibodies—A rare case report
gan: Amr Ashour, et al.
Cyhoeddwyd: (2023-03-01)

Renal Involvement in Antiphospholipid Syndrome
gan: Alonso Turrent-Carriles, et al.
Cyhoeddwyd: (2018-05-01)

Long-Term Anticoagulation Therapy for Antiphospholipid Syndrome Following Unsuccessful Arterial Thrombosis Stent Procedure: A Case Report
gan: Hyun Sik Kang
Cyhoeddwyd: (2023-04-01)

Arterial/venous thrombosis, fetal loss and stillbirth in pregnant women with systemic lupus erythematosus versus primary and secondary antiphospholipid syndrome: a systematic review and meta-analysis
gan: Pravesh Kumar Bundhun, et al.
Cyhoeddwyd: (2018-06-01)

Predictors and clinical complications associated with antiphospholipid antibodies in sickle cell disease
gan: Claudia Rodriguez Rivera, et al.
Cyhoeddwyd: (2023-02-01)

Libman-Sacks endocarditis in patients with systemic lupus erythematosus with secondary antiphospholipid syndrome
gan: Yousef Mohammadi Kebar, et al.
Cyhoeddwyd: (2019-06-01)

Four clinical and biological phenotypes in antiphospholipid syndrome: a cluster analysis of 174 patients with antinuclear antibody tests
gan: Marie Ottavi, et al.
Cyhoeddwyd: (2024-02-01)

Case Report: A case of recurrent thrombosis in pediatric antiphospholipid syndrome associated with pediatric onset systemic lupus
gan: Lingjuan Liu, et al.
Cyhoeddwyd: (2023-02-01)